Nonsmall cell lung cancer with rare exon 7 p.A289V mutation in the EGFR gene responds to Icotinib treatment: A case report

RATIONALE: Mutation p.A289V involving extracellular region of epidermal growth factor receptor (EGFR) exon 7 has not yet been reported in nonsmall cell lung cancer (NSCLC). Studies have shown p.A289V mutation responding to tyrosine kinase inhibitors (TKIs) in glioblastoma cell lines suggesting the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Limeng, Su, Xuejiao, Lu, Lin, Lv, Donglai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319919/
https://www.ncbi.nlm.nih.gov/pubmed/30572543
http://dx.doi.org/10.1097/MD.0000000000013809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319919/
https://www.ncbi.nlm.nih.gov/pubmed/30572543
http://dx.doi.org/10.1097/MD.0000000000013809

Ejemplares similares